TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy-Reference-Cited by-同舟云学术

TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy

Published:2020-05-08 Issue:6 Volume:17 Page:2109-2124
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Kim Hyunjoon¹^ORCID,Khanna Vidhi¹^ORCID,Kucaba Tamara A.²,Zhang Wenqiu¹,Sehgal Drishti²,Ferguson David M.³^ORCID,Griffith Thomas S.²⁴⁵⁶,Panyam Jayanth¹⁴^ORCID

Affiliation:

1. Department of Pharmaceutics, University of Minnesota, Minneapolis, Minnesota 55455, United States

2. Department of Urology, University of Minnesota, Minneapolis, Minnesota 55455, United States

3. Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States

4. Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, United States

5. Center for Immunology, University of Minnesota, Minneapolis, Minnesota 55455, United States

6. Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, Minnesota 55455, United States

Funder

GAP award

Randy Shaver Cancer Research & Community Fund

Prostate and Urological Cancer Translational Working Group

Grant in aid program, University of Minnesota

Masonic Cancer Center, University of Minnesota

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c00271

Reference58 articles.

1. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

2. Randomized Phase III Study of Trastuzumab, Paclitaxel, and Carboplatin Compared With Trastuzumab and Paclitaxel in Women With HER-2–Overexpressing Metastatic Breast Cancer

3. Antibody-Dependent Cellular Cytotoxicity Mediated by Cetuximab against Lung Cancer Cell Lines

4. NK cell-based immunotherapy for malignant diseases

5. NK Cells and Cancer

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacteria‐Mediated Bismuth‐Based Nanoparticles Activate Toll‐Like Receptors for Breast Cancer Photothermal Immunotherapy;Advanced Functional Materials;2024-09-09

2. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review);International Journal of Oncology;2024-09-05

3. Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles;The AAPS Journal;2023-08-17

4. Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy;Advanced Healthcare Materials;2023-08-11

5. Research progress in leveraging biomaterials for enhancing NK cell immunotherapy;Journal of Zhejiang University (Medical Sciences);2023-06-01